Lactulose and Dermatitis exfoliative aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis exfoliative aggravated is reported as a side effect among people who take Lactulose (lactulose), especially for people who are male, 60+ old, also take Vancomycin, and have Haematotoxicity.

The phase IV clinical study analyzes which people have Dermatitis exfoliative aggravated when taking Lactulose. It is created by eHealthMe based on reports of 46,694 people who have side effects when taking Lactulose from the FDA, and is updated regularly.

What is Lactulose?

Lactulose has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 46,960 Lactulose users. Check the latest studies of Lactulose.

What is Dermatitis exfoliative aggravated?

Dermatitis exfoliative aggravated (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss) is found to be associated with 623 drugs and 336 conditions by eHealthMe. Check the latest studies of Dermatitis exfoliative aggravated.

On Jul, 25, 2026

46,694 people reported to have side effects when taking Lactulose.
Among them, 36 people (0.08%) have Dermatitis exfoliative aggravated.

Could Lactulose cause Dermatitis exfoliative aggravated?

Among these 36 people:

What is the gender of people who have Dermatitis exfoliative aggravated when taking Lactulose? *

female: 27.78 %
male: 72.22 %

What is the age of people who have Dermatitis exfoliative aggravated when taking Lactulose? *

What are other drugs people take besides Lactulose? *

What are other side effects people have besides Dermatitis exfoliative aggravated? *

Itching: 9 people, 25.00%
Erythema Multiforme (a type of hypersensitivity reaction): 7 people, 19.44%
Rash Erythematous (redness of the skin): 7 people, 19.44%
Mouth Ulcers: 5 people, 13.89%
Fever: 4 people, 11.11%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 11.11%
Hypotension (abnormally low blood pressure): 4 people, 11.11%
Skin Ulcer: 3 people, 8.33%
Epidermal Necrolysis (skin condition that is usually caused by a reaction to drugs): 3 people, 8.33%
Rashes (redness): 3 people, 8.33%

What are the existing conditions these people have? *

Urinary Tract Infection: 3 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.33%
Haematotoxicity (toxins that destroy red blood cells): 3 people, 8.33%
Weight Decreased: 2 people, 5.56%
Pneumonia: 1 person, 2.78%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 2.78%
Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 1 person, 2.78%
Hiv Infection: 1 person, 2.78%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 2.78%
Bronchial Carcinoma (lung cancer): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Lactulose and have Dermatitis exfoliative aggravated?

- Check whether Dermatitis exfoliative aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lactulose:

Lactulose (46,960 reports)

Browse all side effects of Lactulose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (623 drugs)

Browse all the conditions that are associated with Dermatitis exfoliative aggravated:

Dermatitis exfoliative aggravated (336 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lactulose (the active ingredients of Lactulose) and Lactulose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.